Page 96 - Read Online
P. 96
expression of the cell cycle-dependent kinase inhibitor breast cancer prognostic marker by global gene expression
p27(Kip1). Oncogene 2006;25:1391-9. meta-analysis. Cancer Res 2005;65:11259-64.
17. Wolf I, Bose S, Williamson EA, Miller CW, Karlan BY, 24. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ,
Koeffl er HP. FOXA1: growth inhibitor and a favorable Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR,
prognostic factor in human breast cancer. Int J Cancer Fox EA, Silver PA, Brown M. Chromosome-wide mapping
2007;120:1013-22. of estrogen receptor binding reveals long-range regulation
18. Ho IC, Vorhees P, Marin N, Oakley BK, Tsai SF, Orkin SH, requiring the forkhead protein FoxA1. Cell 2005;122:33-43.
Leiden JM. Human GATA3: a lineage-restricted transcription 25. Carroll JS, Brown M. Estrogen receptor target gene: an
factor that regulates the expression of the T cell receptor gene. evolving concept. Mol Endocrinol 2006;20:1707-14.
EMBO J 1991;10:1187-92. 26. Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F,
19. Hoch RV, Thompson DA, Baker RJ, Weigel RJ. GATA-3 is Giguère V. From the Cover: Location analysis of estrogen receptor
expressed in association with estrogen receptor in breast alpha target promoters reveals that FOXA1 defi nes a domain of the
cancer. Int J Cancer 1999;84:122-8. estrogen response. Proc Natl Acad Sci U S A 2005;102:11651-6.
20. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. 27. Nakshatri H, Badve S. FOXA1 in breast cancer. Expert Rev
GATA-3 maintains the differentiation of the luminal cell fate Mol Med 2009;11:e8.
in the mammary gland. Cell 2006;127:1041-55. 28. Keeple J, Henry-Tillman RS, Klimberg VS, Layeeque R,
21. Kouros-Mehr H, Kim JW, Bechis SK, Werb Z. GATA-3 and Siegel E, Westbrook K, Korourian S. The receptor expression
the regulation of the mammary luminal cell fate. Curr Opin pattern in ductal carcinoma in situ predicts recurrence. Am J
Cell Biol 2008;20:164-70. Surg 2006;192:68-71.
22. Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B,
Extra JM, Houvenaeghel G, Xerri L, Bertucci F, Birnbaum D. How to cite this article: Chivukula M, Picarsic J, Bulusu G, Brufsky A,
Association of GATA3, P53, Ki67 status and vascular Ahrendt G, Carter G. Prognostic signifi cance of transcription factors
peritumoral invasion are strongly prognostic in luminal breast FOXA1 and GATA-3 in ductal carcinoma in situ in terms of recurrence
and estrogen receptor status. J Cancer Metastasis Treat 2015;1:84-9.
cancer. Breast Cancer Res 2009;11:R23.
23. Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Received: 18-12-2014; Accepted: 21-04-2015.
Chinnaiyan AM, Kleer CG. Identifi cation of GATA3 as a Source of Support: Nil, Confl ict of Interest: None declared.
Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 2 ¦ July 15, 2015 ¦ 89